about
A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancerCombination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts.Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.Properties of internalization factors contributing to the uptake of extracellular DNA into tumor-initiating stem cells of mouse Krebs-2 cell line.Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cellsComparative analysis of pathologic processes developing in mice housed in SPF vs non-SPF conditions and treated with cyclophosphamide and dsDNA preparation.Identification of cancer stem cells and a strategy for their elimination.Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas.Nonadherent Spheres With Multiple Myeloma Surface Markers Contain Cells that Contribute to Sphere Formation and Are Capable of Internalizing Extracellular Double-Stranded DNA.Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA.Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma.Cancer Stem Cells: Emergent Nature of Tumor EmergencyIdentification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells"Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNAEffect of double-stranded DNA on maturation of dendritic cells in vitroUltrastructural analysis of the Krebs-2 ascites cancer cells treated with extracellular double-stranded DNA preparationDefective Regulation of Membrane TNFα Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor Cells
P50
Q34330865-1E17A0D6-8871-482F-B249-F10D3EA350C0Q35194151-F683F9C6-0524-4011-B72E-27C17342D727Q35204204-A8117C95-7886-4B68-B3A7-45D4F09EBB06Q36107301-28BFE48A-A5AF-4F1A-BB87-9C6C2B1835CAQ36938161-8191A52B-4861-4506-9367-8BBB8AFDC530Q39056377-4A26D6DE-9BA0-4EFE-9818-EBD84840DC9EQ41040823-B835A7C8-B140-44AB-832F-7FA3BDFC33CCQ41832042-85FE3FD7-CD7B-4094-8C01-D23FE4D8D31DQ47836853-8D5B5EFD-F76F-4EDF-9324-7349272B2F92Q51632567-8B40C28A-ACAC-4523-8CB6-A79023252E8DQ53095961-BF2C5644-D106-4CCE-B842-0482221E0832Q55452001-204BFC9A-171D-49EE-B170-976CDD27F80DQ59798121-AB3A678E-02F1-4488-B0DA-6C3170074888Q64065209-16A002E5-0D2D-48D8-8FFF-1EA36B8C0B2AQ64386585-D52FAD85-7C50-4676-8D1A-CD4B52176DCBQ85071860-B184CEEF-8AF5-4FA3-912B-F2FBA7E161F5Q91538556-F621C3B4-49F9-4D8C-88FC-5254A76D588BQ93187479-9D3666E6-A987-497F-B2BA-C3B552FA45EE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anastasia S Proskurina
@ast
Anastasia S Proskurina
@en
Anastasia S Proskurina
@es
Anastasia S Proskurina
@nl
type
label
Anastasia S Proskurina
@ast
Anastasia S Proskurina
@en
Anastasia S Proskurina
@es
Anastasia S Proskurina
@nl
prefLabel
Anastasia S Proskurina
@ast
Anastasia S Proskurina
@en
Anastasia S Proskurina
@es
Anastasia S Proskurina
@nl
P106
P1153
36599169000
P31
P496
0000-0002-7650-4331